There’s currently an unmet need for effective interventions in early-stage retinal degenerative diseases – before vision is lost. Can three-nanosecond pulse laser therapy meet that need?

Direct visualization delivery of bevacizumab in pseudophakic eyes for the treatment of subretinal neovascularization

The path to truly effective AMD therapies is long and requires us to recognize that it’s not a single disease entity: toil and teamwork are needed to triumph

Sitting Down With...Patricia A. D’Amore, Director, Howe Laboratory; Director of Research, Schepens EyeResearch Institute, and Charles L. Schepens Professor of Ophthalmology, Harvard Medical School, Massachusetts, USA.

Heidelberg Engineering will offer a preview of its cataract and refractive imaging platform* during this year’s Congress of the ESCRS in Barcelona. The platform is based on an upgradable, modular design, which allows to configure each product to the specific diagnostic workflow in a practice or clinic. Main options include: IOL biometry, corneal topography/tomography, anterior segment biometry and anterior segment imaging.

Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology.

Five Things We Learned This Month

Can the combination of 360° haptics and a novel protective membrane, which emulates the pattern found on shark skin, in a single IOL prevent PCO and make YAG laser capsulotomies a thing of the past?

A new ocular biometer automates IOL selection and offers an exciting alternative to sometimes unpredictable IOL power formulae

We interviewed a patient who had undergone refractive lens exchange about her motivation to undergo her surgery, and how she feels about her post-surgical vision. Here is the transcript of that interview.